Immunohistochemical (IHC) stain revealed estrogen receptor (ER)‐positive (> 95% tumor cells), progesterone receptor (PR)‐positive (> 95% tumor cells), and HER2‐negative with an IHC stain of 0. This evidence concerns the gene ERBB2 and neoplasm.